These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8910517)

  • 1. Fusogenic properties of the C-terminal domain of the Alzheimer beta-amyloid peptide.
    Pillot T; Goethals M; Vanloo B; Talussot C; Brasseur R; Vandekerckhove J; Rosseneu M; Lins L
    J Biol Chem; 1996 Nov; 271(46):28757-65. PubMed ID: 8910517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion.
    Pillot T; Lins L; Goethals M; Vanloo B; Baert J; Vandekerckhove J; Rosseneu M; Brasseur R
    J Mol Biol; 1997 Dec; 274(3):381-93. PubMed ID: 9405147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane fusogenic activity of the Alzheimer's peptide A beta(1-42) demonstrated by small-angle neutron scattering.
    Dante S; Hauss T; Brandt A; Dencher NA
    J Mol Biol; 2008 Feb; 376(2):393-404. PubMed ID: 18164313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C-terminal helix of human apolipoprotein AII promotes the fusion of unilamellar liposomes and displaces apolipoprotein AI from high-density lipoproteins.
    Lambert G; Decout A; Vanloo B; Rouy D; Duverger N; Kalopissis A; Vandekerckhove J; Chambaz J; Brasseur R; Rosseneu M
    Eur J Biochem; 1998 Apr; 253(1):328-38. PubMed ID: 9578492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The polar region consecutive to the HIV fusion peptide participates in membrane fusion.
    Peisajovich SG; Epand RF; Pritsker M; Shai Y; Epand RM
    Biochemistry; 2000 Feb; 39(7):1826-33. PubMed ID: 10677233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of the hydrophobicity gradient of an amphipathic peptide to its mode of association with lipids.
    Pérez-Méndez O; Vanloo B; Decout A; Goethals M; Peelman F; Vandekerckhove J; Brasseur R; Rosseneu M
    Eur J Biochem; 1998 Sep; 256(3):570-9. PubMed ID: 9780233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of fluorescently labeled analogues of the amino-terminal fusion peptide of Sendai virus with phospholipid membranes.
    Rapaport D; Shai Y
    J Biol Chem; 1994 May; 269(21):15124-31. PubMed ID: 8195149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific modulation of the fusogenic properties of the Alzheimer beta-amyloid peptide by apolipoprotein E isoforms.
    Pillot T; Goethals M; Vanloo B; Lins L; Brasseur R; Vandekerckhove J; Rosseneu M
    Eur J Biochem; 1997 Feb; 243(3):650-9. PubMed ID: 9057828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular determinants of the interaction between the C-terminal domain of Alzheimer's beta-amyloid peptide and apolipoprotein E alpha-helices.
    Lins L; Thomas-Soumarmon A; Pillot T; Vandekerchkhove J; Rosseneu M; Brasseur R
    J Neurochem; 1999 Aug; 73(2):758-69. PubMed ID: 10428074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusogenic activity of amino-terminal region of HIV type 1 Nef protein.
    Curtain CC; Separovic F; Rivett D; Kirkpatrick A; Waring AJ; Gordon LM; Azad AA
    AIDS Res Hum Retroviruses; 1994 Oct; 10(10):1231-40. PubMed ID: 7848681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane destabilization induced by beta-amyloid peptide 29-42: importance of the amino-terminus.
    Mingeot-Leclercq MP; Lins L; Bensliman M; Van Bambeke F; Van Der Smissen P; Peuvot J; Schanck A; Brasseur R
    Chem Phys Lipids; 2002 Dec; 120(1-2):57-74. PubMed ID: 12426076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects.
    Pereira FB; Goñi FM; Muga A; Nieva JL
    Biophys J; 1997 Oct; 73(4):1977-86. PubMed ID: 9336193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusogenic activity of SIV (simian immunodeficiency virus) peptides located in the GP32 NH2 terminal domain.
    Martin I; Defrise-Quertain F; Mandieau V; Nielsen NM; Saermark T; Burny A; Brasseur R; Ruysschaert JM; Vandenbranden M
    Biochem Biophys Res Commun; 1991 Mar; 175(3):872-9. PubMed ID: 2025261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the N-terminal glycine on the secondary structure, orientation, and interaction of the influenza hemagglutinin fusion peptide with lipid bilayers.
    Gray C; Tatulian SA; Wharton SA; Tamm LK
    Biophys J; 1996 May; 70(5):2275-86. PubMed ID: 9172751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct evidence that the N-terminal heptad repeat of Sendai virus fusion protein participates in membrane fusion.
    Ghosh JK; Shai Y
    J Mol Biol; 1999 Sep; 292(3):531-46. PubMed ID: 10497019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insertion and orientation of a synthetic peptide representing the C-terminus of the A1 domain of Shiga toxin into phospholipid membranes.
    Saleh MT; Ferguson J; Boggs JM; Gariépy J
    Biochemistry; 1996 Jul; 35(29):9325-34. PubMed ID: 8755710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between fusogenicity of synthetic modified peptides corresponding to the NH2-terminal extremity of simian immunodeficiency virus gp32 and their mode of insertion into the lipid bilayer: an infrared spectroscopy study.
    Martin I; Dubois MC; Defrise-Quertain F; Saermark T; Burny A; Brasseur R; Ruysschaert JM
    J Virol; 1994 Feb; 68(2):1139-48. PubMed ID: 8289343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-amyloid peptide interacts specifically with the carboxy-terminal domain of human apolipoprotein E: relevance to Alzheimer's disease.
    Pillot T; Goethals M; Najib J; Labeur C; Lins L; Chambaz J; Brasseur R; Vandekerckhove J; Rosseneu M
    J Neurochem; 1999 Jan; 72(1):230-7. PubMed ID: 9886074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid-interacting properties of the N-terminal domain of human apolipoprotein C-III.
    Lins L; Flore C; Chapelle L; Talmud PJ; Thomas A; Brasseur R
    Protein Eng; 2002 Jun; 15(6):513-20. PubMed ID: 12082170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced efficiency of a targeted fusogenic peptide.
    Decout A; Labeur C; Goethals M; Brasseur R; Vandekerckhove J; Rosseneu M
    Biochim Biophys Acta; 1998 Jun; 1372(1):102-16. PubMed ID: 9651495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.